Security key
097702203
Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT)
CUSIP: 097702203
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 1,901,870
- Total 13F shares
- 887,525
- Share change
- +887,525
- Total reported value
- $5,096,477
- Price per share
- $5.77
- Number of holders
- 24
- Value change
- +$5,096,477
- Number of buys
- 24
Report period
Q2 2025
Institutions
24
Top holders
10
BOLT full security history
Newer quarter: Q3 2025
Bolt Biotherapeutics, Inc. SEC filings
Bolt Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 097702203
Recent filing periods:
Top shareholders of BOLT - Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
9.9%
from 13D/G
|
3,812,773
|
$1,525,109 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
9.1%
|
3,521,291
|
$1,408,516 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
7.2%
|
2,754,437
|
$1,101,775 | — | 31 Mar 2025 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
4.9%
|
1,891,467
|
$756,587 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,169,705
|
$467,882 | — | 31 Mar 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
3%
|
1,166,952
|
$466,781 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2.7%
|
1,049,153
|
$419,661 | — | 31 Mar 2025 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
1.9%
|
719,546
|
$287,818 | — | 31 Mar 2025 | |
| PFIZER INC |
13F
|
Company |
1.6%
|
626,109
|
$250,444 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
375,113
|
$150,079 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.82%
|
314,139
|
$125,656 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.7%
|
268,640
|
$107,456 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.64%
|
244,966
|
$97,986 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
111,508
|
$44,603 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.22%
|
83,893
|
$33,557 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
47,437
|
$18,975 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
40,895
|
$16,358 | — | 31 Mar 2025 | |
| Mariner, LLC |
13F
|
Company |
0.1%
|
40,000
|
$16,000 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
21,733
|
$8,693 | — | 31 Mar 2025 | |
| StoneX Group Inc. |
13F
|
Company |
0.04%
|
15,532
|
$6,213 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
15,392
|
$6,157 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
11,615
|
$4,646 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
8,688
|
$3,475 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.02%
|
8,100
|
$3,240 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
5,628
|
$2,251 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
906
|
$362 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
200
|
$80 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
139
|
$56 | — | 31 Mar 2025 | |
| SALEM INVESTMENT COUNSELORS INC |
13F
|
Company |
0%
|
40
|
$16 | — | 31 Mar 2025 | |
| Vivo Capital VIII, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
5,763,311
mixed-class rows
|
$5,435,517 | — | 21 Nov 2023 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,703,991
|
$3,518,791 | — | 13 Jul 2022 | |
| Edgar Engleman |
3/4/5
|
Director |
—
mixed-class rows
|
2,098,005
mixed-class rows
|
$1,969,355 | — | 29 Nov 2023 | |
| Edith A. Perez |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
281,612
mixed-class rows
|
$36,451 | — | 04 Mar 2024 | |
| Randall C. Schatzman |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
247,859
mixed-class rows
|
$10,056 | — | 04 Mar 2024 | |
| David Dornan |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
210,000
|
— | — | 18 Feb 2022 | |
| Richard A. Miller MD |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 12 Jun 2023 | |
| Frank D. Lee |
3/4/5
|
Director |
—
class O/S missing
|
22,000
|
— | — | 12 Jun 2024 | |
| James Healy |
3/4/5
|
Director |
—
class O/S missing
|
22,000
|
— | — | 12 Jun 2024 | |
| Mahendra Shah |
3/4/5
|
Director |
—
class O/S missing
|
22,000
|
— | — | 12 Jun 2024 |
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) as of Q2 2025
As of 30 Jun 2025,
Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
887,525 shares.
The largest 10 holders included
Vivo Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sofinnova Investments, Inc., Pivotal bioVenture Partners Investment Advisor LLC, VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, SAMSARA BIOCAPITAL, LLC, Board of Trustees of The Leland Stanford Junior University, Pfizer Inc, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
21
Q2 2025 holders
24
Holder diff
3
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.